Philadelphia youth see rise in diagnosis; especially for African Americans, by 70%.
Read More »Efficacy and Safety of Diacerein With Inadequately Controlled Type 2 Diabetes
Common osteoarthritis treatment may be beneficial in lowering HbA1c.
Read More »Intensive Control Again Shows Greater Benefits
Intensive control of blood pressure, glucose, and lipids benefits patients with type 2 diabetes, the long-awaited, large Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases (J-DOIT3).
Read More »Ertugliflozin, An SGLT-2, Meets Goals in Two Phase 3 Trials
The investigational sodium/glucose cotransporter 2 (SGLT2) inhibitor ertugliflozin (Merck), being developed to improve glycemic control in adults with type 2 diabetes, met the primary outcomes in two yearlong phase 3 trials, VERTIS SU and VERTIS SITA2.
Read More »SGLT-2 Inhibitors Safer and More Effective Than DPP-4s For Heart
New study finds lower occurrence of heart failure in older people with type 2.
Read More »PCPs Lack Knowledge of Prediabetes Risk
Recent published study showed that health care providers may lack the knowledge to diagnose and even treat prediabetes.
Read More »Predicting Atherosclerosis Disease in Patients With Diabetes
Carotid ultrasound shows atherosclerotic disease is not just a concern for patients with type 1 and type 2 diabetes, but LADA as well.
Read More »Age At Menopause and Type 2 Diabetes Risk
Early onset menopause linked to increased risk of type 2 diabetes in a cohort study.
Read More »Dyslipidemia Pattern And Ischemic Heart Disease In Type 2 Diabetes Patients
Research suggests screening for latent coronary artery disease to decrease complications.
Read More »Obesity and Life Expectancy in Older Diabetes Patients
The treatment of choice for obese T2D patients is weight loss.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.